THERE is a general consensus of medical opinion that the digitalis group of drugs is by far the most valuable in the treatment of cardiac disease. The vast literature which has grown up around the subject affords ample evidence of the therapeutic value of the drugs and also of the frequency with which they are used. On the other hand, the number in the group and the large variety of their preparations are in sharp contrast with drugs of the opium type, and probably exist because the therapeutic exhibition of the group is not always followed by the expected result. In fact it is generally recognized that the therapeutic effect of digitalis does not always follow its exhibition. For this I believe there may be two reasons: (1) That it is used for clinical conditions in which it is not likely to act; (2) that the preparation used is not of adequate potency. I take it as an axiom that the result expected from digitalis is cardiac slowing.
THERE is a general consensus of medical opinion that the digitalis group of drugs is by far the most valuable in the treatment of cardiac disease. The vast literature which has grown up around the subject affords ample evidence of the therapeutic value of the drugs and also of the frequency with which they are used. On the other hand, the number in the group and the large variety of their preparations are in sharp contrast with drugs of the opium type, and probably exist because the therapeutic exhibition of the group is not always followed by the expected result. In fact it is generally recognized that the therapeutic effect of digitalis does not always follow its exhibition. For this I believe there may be two reasons: (1) That it is used for clinical conditions in which it is not likely to act; (2) that the preparation used is not of adequate potency. I take it as an axiom that the result expected from digitalis is cardiac slowing.
Proper Use.-There is a vast amount of evidence that digitalis will act with almost absolute certainty and in the way indicated, when the speed of the heart is raised by auricular fibrillation. The evidence that it will act when the speed is raised from other causes is equivocal. Mackenzie and many others have published evidence that no cardiac slowing is produced by digitalis when given in adequate doses to patients whose cardiac speed is raised from causes other than auricular fibrillation.
Inactive Preparations.-It is now almost universal practice to submit samples of digitalis preparations to some form of biological assay, and therefore it is unlikely that any preparation reaches the market which is totally inactive. On the other hand, clinical experience has shown that great varieties in the potency of some preparations certainly do occur.
Biological assay is resorted to, presumably, because no satisfactory methods of chemical estimation have been found, and no agreement has as yet been reached as to which of the several glucosides is responsible for the clinical desiderata. From the clinician's point of view, perfusion or injection methods of standardization are not very acceptable, when applied to a drug which he intends to administer orally. It might well be that the part of the drug which yields the observed results on injection, would not even be absorbed when given by mouth. There is the further objection that evidence is very equivocal which would show that digitalis has any effect whatever, in therapeutic doses, upon hearts retaining normal rhythm; any form of assay against normally beating hearts would not necessarily apply at all to hearts in auricular fibrillation, the condition for which the clinician chiefly intends to use the drug. Biological assay by the oral route against experimentally fibrillating hearts, has not been attempted so far as I know. It is not easily done, and suffers from the defect that fibrillation in experimental animals is liable to lapse into normal rhythm on removal of the generating agent. It is still possible, however, that methods of biological assay do really test the preparations for an effect which is identical with that utilized in the treatment of auricular fibrillation, or that the test, thus applied under different conditions and for a different purpose, yet yields a result which precisely parallels the effect utilized in the clinical application of the drug. (1) Slowing of ventricular rate.
(2) Alteration in direction of the T wave of the electrocardium in lead 2.
(3) The occurrence of ventricular extrasystoles.
(4) Vomiting.
In this work, no account has been taken of the general impressions of clinical improvements, as every clinician sees such through rose-coloured spectacles, nor of the diuresis, as this is now generally believed to be merely proportionate to the cedema present. The size of the heart is too difficult to judge. Diminution of dyspncea may or may not occur, according to the degree of the hydrothorax and ascites present. The other well-known factors appeared too difficult to estimate for the purpose in view. Some justification must be offered for the selection of these criteria. Slowing of the ventricular rate is the most usual aim of digitalis therapy. It is well known to depend upon auriculo-ventricular block of varying degree. This is not demonstrable in auricular fibrillation, for the auricular undulation speed is usually 420 per minute, and the ventricular speed will depend upon two variable factors: (a) The numbers of auricular impulses reaching the auriculo-ventricular bundle, and (b) the capacity of the bundle to conduct. The speed of auricular undulations is but little affected by digitalis, but the conductivity of the bundle is materially reduced. No preparation of digitalis would be regarded as useful by the clinician which did not yield a marked slowing in auricular fibrillation of high speed. The remaining three factors, T-wave inversion, ventricular extrasystoles, and vomiting, are usually recognized as early toxic signs, occurring in the order arranged.
There is much evidence to show that the optimum therapeutic dose and the toxic dose of digitalis lie very close together and represent about 50 per cent. of the lethal dose. To be certain that any given case has been offered the full advantage of digitalization, it is necessary to establish vomiting, which has been shown not to occur when the cardiac nerves are cut, and to be dependent upon stimuli arising in the heart and acting centrally. On the otber hand, this work has been a clinical study and limits are imposed upon the method of inquiry. The majority of these patients are very ill, most of them have been orthopnceic and anasarcic with complete cardiac breakdown. To establish vomiting, with its distress and its danger to these unfortunate sufferers, must and should be regarded as a clinical blunder. To avoid the disaster of vomiting and achieve full digitalization is the chief aim of standardization of this drug. It is believed that T-wave inversion occurs before the dose which causes vomiting is reached, and it is common experience that bigeminy gives a valuable warning of digitalization. By making use of this observation the clinician can push continuous digitalis treatment without causing vomiting.
An adequate and trustworthy standardization of digitalis tincture is vitally important if patients are to be given the full advantage of massive digitalis therapy.
Much of the difficulty in this work has arisen from the fact that a change in the preparation has necessitated a change in the rate per pound at which a full therapeutic effect can be produced without undesirable toxic effects. Fifty cases of auricular fibrillation have been treated by the method described, and seven different preparations have been used (Table I) . The results are summarized in Table II . In the first column, beside the identification number of the preparation, is the potency of the preparation, expressed as a percentage of the international standard. It is quite obvious that this is only a preliminary note.
The number of cases treated with each preparation is small, but it must be remembered that, for this study, patients had to be found who not only required this particular line of treatment, but also agreed to come into hospital for the purpose. Freedom from any previous digitalis is the factor most difficult to secure, for the majority of patients coming under observation have already been given some digitalis, and it is frequently unjustifiable to wait the necessary three weeks before giving a massive dose.
The tablets were given at the rate of one for every ten pounds body-weight. Each tablet was reputed to represent 1 c.c. of the tincture. The results were very Langley: Digitalis: Its Clinical Standardization satisfactory, and toxic effects were not marked. The preparation C/171 was not at all satisfactory, and its routine use in the heart clinic resulted in a rise in speed in all the cases under continued digitalis control (Table III) . The prepa'ration was, therefore, given up, on the grounds of being too low in potency. The preparation BT/H gave rise to very marked toxic signs, more so than any other preparation. The reduction in speed was satisfactory, but -three of the five patients were made very ill, and the tincture was regarded as too toxic for clinical use. It is this preparation which offers the greatest interest. The tincture W.T. was the first one used in this inquiry. I think it was a weak tincture, but it was used at a low rate and did not give at all satisfactory results, the degree of slowing being small. The tincture U gave satisfactory cardiac slowing without any toxic signs whatever, in spite of the fact that biologically it was regarded as of high potency. The tincture D was obviously weak, gave no toxic effects, and only a very poor speed reduction. For clinical use the dose would have to be considerably raised. index of potency, provided the toxic element in the product is not too obtrusive. From the clinical standpoint, vomiting has been regarded as the sure index of full digitalization, but from this work it would appear that this is not necessarily so, and that in the same cases emesis may result from toxicity before adequate slowing has been obtained.
Of the four patients who had received treatment with two different preparations (Table IV) , some months separated each administration. But we may conclude that the tablets are more potent than D, that H is much more toxic than D, and probably rather more effective, that H.H. is more effective than D, and that W.T. is more effective than U. These results would correspond to the assay indications, except the last.
CONCLUSIONS.
(1) Reliable biological assay for digitalis is urgently needed.
(2) Such standardization is essential if the full benefit of Eggleston's massive method of administration is to be obtained. (5) Some preparations are unduly toxic in proportion to their capacity to produce cardiac slowing. Attempts should be made to assay this toxicity factor separately. 
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One other case reduced ill speed. The clinic is held weekly, and pulse-rates, or rather heart-rates, are recorded each day. 
